ARCHIVES

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

This article is from The Cancer Letter archive.

Vol. 06 No. 45 | November 14, 1980

Download PDF Visit The Full Archive

Related Articles

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Alan Rabson Named Acting NCI Director

October 5, 2001

50-Gene Set Identifies Known Types Of Breast Cancer

February 27, 2009

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

Abstracts From AACR Annual Meeting

May 21, 1976